Literature DB >> 18465053

Renal tubular function in patients with beta-thalassaemia major in Zahedan, southeast Iran.

S Sadeghi-Bojd1, M Hashemi, M Karimi.   

Abstract

INTRODUCTION: In patients with beta-thalassaemia major, impaired biosynthesis of the beta-globin leads to accumulation of unpaired alpha-globin chain. Shortened red cell lifespan and iron overload cause functional and physiological abnormalities in various organ systems. Thus, in patients with beta-thalassaemia major, the most important cause of mortality and morbidity is organ failure due to deposits of iron. The aim of this study is to investigate renal tubular and glomerular functions in patients with beta-thalassaemia major.
METHODS: 166 subjects with beta-thalassaemia major (96 male, 70 female) were enrolled in the study. Fasting blood and 24-hour urine samples were obtained for haematological and biochemical analyses.
RESULTS: Patients with beta-thalassaemia major showed significant signs of renal tubulopathy, such as hypercalciuria (12.9 percent), proteinuria (8.6 percent), phosphaturia (9.2 percent), magnesiumuria (8.6 percent), hyperuricosuria (38 percent) and excretion of beta-2 microglobin (13.5 percent). We found that 95.1 percent of patients had iron overload (ferritin more than 1,000 ng/ml).
CONCLUSION: The determination of biochemical indices of renal function might help prevention of serious kidney damage before any clinical symptom is observed. Beta-thalassaemia patients present multiple renal abnormalities which may be due to iron overload. We suggest the appropriate chelation therapy and regular monitoring of the status of iron overload.

Entities:  

Mesh:

Year:  2008        PMID: 18465053

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  14 in total

Review 1.  Renal complications of beta-thalassemia major in children.

Authors:  Ashraf Bakr; Youssef Al-Tonbary; Ghada Osman; Rasha El-Ashry
Journal:  Am J Blood Res       Date:  2014-09-05

2.  GFR in Patients with β-Thalassemia Major.

Authors:  Gai Milo; Revital Feige Gross Nevo; Idit Pazgal; Anat Gafter-Gvili; Ofer Shpilberg; Uzi Gafter; Arie Erman; Pinhas Stark
Journal:  Clin J Am Soc Nephrol       Date:  2015-05-11       Impact factor: 8.237

3.  Renal dysfunction in patients with thalassaemia.

Authors:  Charles T Quinn; Valerie L Johnson; Hae-Young Kim; Felicia Trachtenberg; Maria G Vogiatzi; Janet L Kwiatkowski; Ellis J Neufeld; Ellen Fung; Nancy Oliveri; Melanie Kirby; Patricia J Giardina
Journal:  Br J Haematol       Date:  2011-02-21       Impact factor: 6.998

Review 4.  Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507

5.  Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients.

Authors:  Mozhgan Hashemieh; Mitra Radfar; Azita Azarkeivan; Seyed Mohammad Taghi Hosseini Tabatabaei; Sedigheh Nikbakht; Mehdi Yaseri; Kourosh Sheibani
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-04-01

6.  Glomerular and Tubular Functions in Children and Adults with Transfusion-Dependent Thalassemia.

Authors:  Agageldi Annayev; Zeynep Karakaş; Serap Karaman; Altan Yalçıner; Alev Yılmaz; Sevinç Emre
Journal:  Turk J Haematol       Date:  2017-07-28       Impact factor: 1.831

Review 7.  A contemporary therapeutic approach to bone disease in beta-thalassemia - a review.

Authors:  Dimitrios Stefanopoulos; Nikolaos A Papaioannou; Athanassios G Papavassiliou; George Mastorakos; Andromachi Vryonidou; Aikaterini Michou; Ismene A Dontas; George Lyritis; Eva Kassi; Symeon Tournis
Journal:  J Frailty Sarcopenia Falls       Date:  2018-03-01

8.  Genetic Variation Impacts in Patients with Major Beta-Thalassemia.

Authors:  Maliheh Najaf Pour; Majid Farshdousti Hagh; Ali Akbar Movasagpoor Akbari; Abbas Ali Hosein Poor Feyzi; Majid Malaki
Journal:  Iran J Public Health       Date:  2015-05       Impact factor: 1.429

9.  Therapeutic value of combined therapy with deferasirox and silymarin on iron overload in children with Beta thalassemia.

Authors:  Adel A Hagag; Mohamed S Elfrargy; Rana A Gazar; Aml Ezzat Abd El-Lateef
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

10.  Role of serum cystatin-C and beta-2 microglobulin as early markers of renal dysfunction in children with beta thalassemia major.

Authors:  Ola Galal Behairy; Eman Rateb Abd Almonaem; Neveen Tawfik Abed; Omima M Abdel Haiea; Rasha M Zakaria; Rania I AbdEllaty; Effat H Asr; Amira Ibrahim Mansour; Amira Mn Abdelrahman; Hoda A Elhady
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.